Open-label, phase 2, randomized controlled multicenter study comparing niraparib versus platinum-taxane doublet chemotherapy as neoadjuvant treatment in participants with homologous recombination deficient stage III/IV ovarian cancer: Trial in progress (1252)

Saved in:
Bibliographic Details
Published in:Gynecologic oncology 2023-09, Vol.176, p.S159-S160
Main Authors: Zeng, Xing, Belotte, Jimmy, Felicetti, Brunella, Baines, Amanda, Youssefagha, Ahmed, Rojas-Espaillat, Luis, Ortiz, Ana Godoy, Provencher, Diane, Vázquez, Raúl Márquez, González-Cortijo, Lucia
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0090-8258
1095-6859
DOI:10.1016/j.ygyno.2023.06.161